February 6, 2020 / 10:15 AM / 10 days ago

BRIEF-Roche's risdiplam boosted motor function in older SMA patients - study

Feb 6 (Reuters) - Roche Holding AG:

* ROCHE'S RISDIPLAM SHOWED SIGNIFICANT IMPROVEMENT IN MOTOR FUNCTION IN PEOPLE AGED 2-25 WITH TYPE 2 OR 3 SPINAL MUSCULAR ATROPHY

* FIRST PLACEBO-CONTROLLED TRIAL TO INCLUDE ADULTS WITH SMA DEMONSTRATES RISDIPLAM IMPROVED OR STABILISED MOTOR FUNCTION

* MEDICALLY MEANINGFUL AND STATISTICALLY SIGNIFICANT RESULTS IN PRIMARY AND KEY SECONDARY ENDPOINTS Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below